Identifying and Ranking Causal Biochemical Biomarkers for Breast Cancer: a Mendelian Randomisation Study

Overview

Journal BMC Med

Publisher Biomed Central

Specialty General Medicine

Date 2022 Nov 24

PMID 36424572

Authors

Sonja N Tang

Verena Zuber

Konstantinos K Tsilidis

Affiliations

Soon will be listed here.

Abstract

Background: Only a few of the 34 biochemical biomarkers measured in the UK Biobank (UKB) have been associated with breast cancer, with many associations suffering from possible confounding and reverse causation. This study aimed to screen and rank all UKB biochemical biomarkers for possible causal relationships with breast cancer.

Methods: We conducted two-sample Mendelian randomisation (MR) analyses on ~420,000 women by leveraging summary-level genetic exposure associations from the UKB study (n = 194,174) and summary-level genetic outcome associations from the Breast Cancer Association Consortium (n = 228,951). Our exposures included all 34 biochemical biomarkers in the UKB, and our outcomes were overall, oestrogen-positive, and oestrogen-negative breast cancer. We performed inverse-variance weighted MR, weighted median MR, MR-Egger, and MR-PRESSO for 30 biomarkers for which we found multiple instrumental variables. We additionally performed multivariable MR to adjust for known risk factors, bidirectional MR to investigate reverse causation, and MR Bayesian model averaging to rank the significant biomarkers by their genetic evidence.

Results: Increased genetic liability to overall breast cancer was robustly associated with the following biomarkers by decreasing importance: testosterone (odds ratio (OR): 1.12, 95% confidence interval (CI): 1.04-1.21), high-density lipoprotein (HDL) cholesterol (OR: 1.08, 95% CI: 1.04-1.13), insulin-like growth factor 1 (OR: 1.08, 95% CI: 1.02-1.13), and alkaline phosphatase (ALP) (OR: 0.93, 95% CI: 0.89-0.98).

Conclusions: Our findings support a likely causal role of genetically predicted levels of testosterone, HDL cholesterol, and IGF-1, as well as a novel potential role of ALP in breast cancer aetiology. Further studies are needed to understand full disease pathways that may inform breast cancer prevention.

Citing Articles

Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review.

Leone A, Bonadonna S, Cassani C, Barcellini A, Sirico M, Tagliaferri B BMJ Oncol. 2025; 3(1):e000330.

PMID: 39886120 PMC: 11235029. DOI: 10.1136/bmjonc-2024-000330.

Identifying causal relationships between 35 blood and urine biomarkers and urologic cancers: MR-meta combined with Bayesian colocalization Mendelian randomization analysis.

An W, Zhao C, Wang Y, Zhang Y, Qiao Z Discov Oncol. 2024; 15(1):617.

PMID: 39495393 PMC: 11534928. DOI: 10.1007/s12672-024-01493-0.

Construction of a nomogram model for predicting the outcome of debulking surgery for ovarian cancer on the basis of clinical indicators.

Si Y, Song N, Ji Y Front Oncol. 2024; 14:1421247.

PMID: 39050577 PMC: 11266020. DOI: 10.3389/fonc.2024.1421247.

Breast Cancer Screening and Prophylactic Mastectomy for High-Risk Women in Romania.

Filip C, Catana A, Kutasi E, Roman S, Militaru M, Risteiu G Medicina (Kaunas). 2024; 60(4).

PMID: 38674216 PMC: 11052261. DOI: 10.3390/medicina60040570.

Obesity-Dependent Association of the rs10454142 with Breast Cancer.

Ponomarenko I, Pasenov K, Churnosova M, Sorokina I, Aristova I, Churnosov V Biomedicines. 2024; 12(4).

PMID: 38672173 PMC: 11048332. DOI: 10.3390/biomedicines12040818.

References

Sinnott-Armstrong N, Tanigawa Y, Amar D, Mars N, Benner C, Aguirre M . Genetics of 35 blood and urine biomarkers in the UK Biobank. Nat Genet. 2021; 53(2):185-194. PMC: 7867639. DOI: 10.1038/s41588-020-00757-z. View

Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne R . Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013; 45(4):353-61, 361e1-2. PMC: 3771688. DOI: 10.1038/ng.2563. View

Wulaningsih W, Sagoo H, Hamza M, Melvin J, Holmberg L, Garmo H . Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies. Int J Mol Sci. 2016; 17(9). PMC: 5037765. DOI: 10.3390/ijms17091487. View

Michailidou K, Beesley J, Lindstrom S, Canisius S, Dennis J, Lush M . Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nat Genet. 2015; 47(4):373-80. PMC: 4549775. DOI: 10.1038/ng.3242. View

Dimou N, Papadimitriou N, Gill D, Christakoudi S, Murphy N, Gunter M . Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization study. Int J Epidemiol. 2019; 48(3):807-816. PMC: 6659370. DOI: 10.1093/ije/dyz107. View

Burgess S, Thompson S . Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015; 181(4):251-60. PMC: 4325677. DOI: 10.1093/aje/kwu283. View

Murphy N, Knuppel A, Papadimitriou N, Martin R, Tsilidis K, Smith-Byrne K . Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women. Ann Oncol. 2020; 31(5):641-649. PMC: 7221341. DOI: 10.1016/j.annonc.2020.01.066. View

Burgess S, Davey Smith G, Davies N, Dudbridge F, Gill D, Glymour M . Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2023; 4:186. PMC: 7384151. DOI: 10.12688/wellcomeopenres.15555.3. View

Beeghly-Fadiel A, Khankari N, Delahanty R, Shu X, Lu Y, Schmidt M . A Mendelian randomization analysis of circulating lipid traits and breast cancer risk. Int J Epidemiol. 2019; 49(4):1117-1131. PMC: 7750975. DOI: 10.1093/ije/dyz242. View

10.

Jung S, Wang M, Anderson K, Baglietto L, Bergkvist L, Bernstein L . Alcohol consumption and breast cancer risk by estrogen receptor status: in a pooled analysis of 20 studies. Int J Epidemiol. 2015; 45(3):916-28. PMC: 5005939. DOI: 10.1093/ije/dyv156. View

11.

Ni H, Liu H, Gao R . Serum Lipids and Breast Cancer Risk: A Meta-Analysis of Prospective Cohort Studies. PLoS One. 2015; 10(11):e0142669. PMC: 4640529. DOI: 10.1371/journal.pone.0142669. View

12.

Michailidou K, Lindstrom S, Dennis J, Beesley J, Hui S, Kar S . Association analysis identifies 65 new breast cancer risk loci. Nature. 2017; 551(7678):92-94. PMC: 5798588. DOI: 10.1038/nature24284. View

13.

Zuber V, Colijn J, Klaver C, Burgess S . Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization. Nat Commun. 2020; 11(1):29. PMC: 6946691. DOI: 10.1038/s41467-019-13870-3. View

14.

Sanderson E, Glymour M, Holmes M, Kang H, Morrison J, Munafo M . Mendelian randomization. Nat Rev Methods Primers. 2023; 2. PMC: 7614635. DOI: 10.1038/s43586-021-00092-5. View

15.

Ye Y, Yang H, Wang Y, Zhao H . A comprehensive genetic and epidemiological association analysis of vitamin D with common diseases/traits in the UK Biobank. Genet Epidemiol. 2020; 45(1):24-35. DOI: 10.1002/gepi.22357. View

16.

Flynn E, Tanigawa Y, Rodriguez F, Altman R, Sinnott-Armstrong N, Rivas M . Sex-specific genetic effects across biomarkers. Eur J Hum Genet. 2020; 29(1):154-163. PMC: 7794464. DOI: 10.1038/s41431-020-00712-w. View

17.

Robinson T, Martin R, Yarmolinsky J . Mendelian randomisation analysis of circulating adipokines and C-reactive protein on breast cancer risk. Int J Cancer. 2020; 147(6):1597-1603. PMC: 7497166. DOI: 10.1002/ijc.32947. View

18.

Burgess S, Butterworth A, Thompson S . Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658-65. PMC: 4377079. DOI: 10.1002/gepi.21758. View

19.

Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P . Breast cancer. Nat Rev Dis Primers. 2019; 5(1):66. DOI: 10.1038/s41572-019-0111-2. View

20.

Boyle P, Koechlin A, Pizot C, Boniol M, Robertson C, Mullie P . Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis. Eur J Nutr. 2012; 52(5):1533-40. DOI: 10.1007/s00394-012-0460-z. View